Circulating Ceramide: A New Cardiometabolic Biomarker in Patients With Comorbid Acute Coronary Syndrome and Type 2 Diabetes Mellitus

Circulating Ceramide: A New Cardiometabolic Biomarker in Patients With Comorbid Acute Coronary Syndrome and Type 2 Diabetes Mellitus

AimsThis study investigated the association of circulating ceramides in patients with comorbid acute coronary syndrome and type 2 diabetes mellitus (ACS-DM).MethodsA total of 761 patients with coronary heart disease who were admitted to the Department of Cardiology at the Chinese PLA General Hospita...

Full description

Bibliographic Details
Main Authors: Ruihua Cao, Zhiyi Fang, Sulei Li, Mengqi Xu, Jibin Zhang, Dong Han, Wenchao Hu, Liqiu Yan, Yabin Wang, Li Fan, Feng Cao
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-09-01
Series:Frontiers in Physiology
Subjects:
ceramide
acute coronary syndrome with type 2 diabetes mellitus
comorbidity
cardiometabolic diseases
risk factors
Online Access:https://www.frontiersin.org/article/10.3389/fphys.2020.01104/full

Internet

https://www.frontiersin.org/article/10.3389/fphys.2020.01104/full

Similar Items